Addus HomeCare (NASDAQ:ADUS) Stock Moved Up to Strong-Buy by Zacks Research

Posted by George Bondi on Nov 12th, 2026

Addus HomeCare (NASDAQ:ADUS – Get Free Report) was upgraded by Zacks Research from a “hold” rating to a “strong-buy” rating in a report issued on Tuesday, Zacks reports.

Several other equities research analysts have also recently weighed in on the company. Truist Financial boosted their target price on Addus HomeCare from $135.00 to $148.00 and gave the stock a “buy” rating in a research note on Thursday, November 5th. UBS Group increased their price target on shares of Addus HomeCare from $145.00 to $160.00 and gave the company a “buy” rating in a research note on Thursday, November 5th. Royal Bank Of Canada raised their price objective on shares of Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. TD Cowen boosted their price objective on shares of Addus HomeCare from $131.00 to $145.00 and gave the stock a “buy” rating in a research report on Thursday, November 5th. Finally, Bank of America downgraded shares of Addus HomeCare from a “buy” rating to a “neutral” rating and dropped their target price for the company from $140.00 to $125.00 in a research report on Monday, September 14th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $134.70.

Get Our Latest Stock Report on Addus HomeCare

Addus HomeCare Stock Performance

Shares of ADUS stock opened at $125.49 on Tuesday. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.02. The firm has a fifty day moving average price of $118.19 and a 200 day moving average price of $107.10. The company has a market cap of $2.34 billion, a P/E ratio of 20.91, a PEG ratio of 1.66 and a beta of 0.75. Addus HomeCare has a 12 month low of $87.95 and a 12 month high of $131.59.

Addus HomeCare (NASDAQ:ADUS – Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported $1.83 earnings per share for the quarter, beating analysts’ consensus estimates of $1.79 by $0.04. The company had revenue of $387.74 million for the quarter, compared to analysts’ expectations of $388.72 million. Addus HomeCare had a return on equity of 10.22% and a net margin of 7.39%. Addus HomeCare’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period last year, the firm earned $1.56 earnings per share. Sell-side analysts predict that Addus HomeCare will post 6.41 earnings per share for the current fiscal year.

Insider Activity

In other Addus HomeCare news, EVP Brian Poff sold 6,644 shares of Addus HomeCare stock in a transaction that occurred on Friday, November 6th. The stock was sold at an average price of $124.72, for a total value of $828,639.68. Following the transaction, the executive vice president directly owned 57,048 shares in the company, valued at approximately $7,115,026.56. This trade represents a 10.43% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP David W. Tucker sold 14,850 shares of Addus HomeCare stock in a transaction that occurred on Friday, November 6th. The shares were sold at an average price of $124.75, for a total value of $1,852,537.50. Following the completion of the transaction, the executive vice president owned 8,073 shares in the company, valued at $1,007,106.75. This trade represents a 64.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 131,655 shares of company stock worth $16,275,572 over the last quarter. 4.10% of the stock is owned by insiders.

Institutional Investors Weigh In On Addus HomeCare

Several large investors have recently modified their holdings of ADUS. Private Wealth Asset Management LLC acquired a new position in Addus HomeCare in the 3rd quarter valued at $187,000. Private Advisor Group LLC lifted its stake in shares of Addus HomeCare by 15.5% in the 3rd quarter. Private Advisor Group LLC now owns 2,940 shares of the company’s stock worth $325,000 after acquiring an additional 394 shares during the period. Boston Partners lifted its stake in shares of Addus HomeCare by 18.0% in the 3rd quarter. Boston Partners now owns 290,332 shares of the company’s stock worth $32,222,000 after acquiring an additional 44,279 shares during the period. Global Retirement Partners LLC boosted its holdings in shares of Addus HomeCare by 270.4% in the third quarter. Global Retirement Partners LLC now owns 900 shares of the company’s stock valued at $99,000 after acquiring an additional 657 shares in the last quarter. Finally, Hantz Financial Services Inc. boosted its holdings in shares of Addus HomeCare by 21.3% in the third quarter. Hantz Financial Services Inc. now owns 620 shares of the company’s stock valued at $69,000 after acquiring an additional 109 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

More Addus HomeCare News

These are some of the ADUS news items that stood out recently:

Neutral Sentiment: Addus plans to participate in the 2026 Stephens Annual Investment Conference. The announcement offers investor access but provides no new operating or financial guidance. Article: Addus HomeCare to Participate in 2026 Stephens Annual Investment Conference
Neutral Sentiment: A report claims short interest was zero shares, despite describing it as a large increase. The conflicting wording makes the short-interest update difficult to interpret.
Negative Sentiment: Several executives sold shares on Nov. 6, and CEO R. Allison sold 98,958 shares on Nov. 9 for about $12.2 million, reducing his stake by 35.08%. Five executive vice presidents also sold a combined 32,697 shares. The volume of insider selling may weigh on investor sentiment, though sales alone do not establish a negative view of the company. CEO sale filing Article: EVP share sale

Addus HomeCare Company Profile

(Get Free Report)

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.